IGM Biosciences (NASDAQ: IGMS), a biotechnology company, has seen a sharp 67% drop in its stock value on Friday following the suspension of two of its treatments ...

IGM Biosciences is again cutting staff as it scraps an autoimmune-drug trial after failing to achieve the desired results.

RheumaGen, Inc., a cell and gene therapy company engineering a new class of therapeutics for major autoimmune diseases, announced today the close of a $15 million Series A financing co-led by SPRIM ...

Artificial intelligence (AI) can significantly aid in early detection of autoimmune diseases, like rheumatoid arthritis and ...

A once-daily dose of ivarmacitinib reduced disease activity and improved function among patients with rheumatoid arthritis ...

Now, AI technology can help in early detection of diseases like arthritis and lupus. | Health News | Patrika News ...

Anemia is prevalent among patients with rheumatoid arthritis, according to study findings published in Cureus.

OMNY Health, the leading healthcare ecosystem for compliant real-world data insights at scale, and Scipher Medicine, which ...

Rheumatoid arthritis (RA) and inflammatory bowel disease (IBD) belong to the most common chronic inflammatory diseases (CIDs). While significant research efforts have led to improvements in treatment, ...

A study published in Cureus has highlighted the high prevalence of anemia among patients with rheumatoid arthritis (RA).

High serum CXCL13 levels are predictive of treatment failure with first-line MTX among patients with early RA.